BCM
Bayesian Capital Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,000
| Closed | -$276K | – | 873 |
|
|
2025
Q1 | $276K | Buy |
+7,000
| New | +$276K | 0.05% | 409 |
|
|
2024
Q3 | – | Sell |
-105,567
| Closed | -$1.88M | – | 1035 |
|
|
2024
Q2 | $1.88M | Buy |
105,567
+61,300
| +138% | +$1.09M | 0.22% | 124 |
|
|
2024
Q1 | $673K | Sell |
44,267
-71,800
| -62% | -$1.09M | 0.06% | 376 |
|
|
2023
Q4 | $1.98M | Buy |
+116,067
| New | +$1.98M | 0.21% | 130 |
|
|
2023
Q3 | – | Sell |
-45,667
| Closed | -$1.13M | – | 1001 |
|
|
2023
Q2 | $1.13M | Buy |
+45,667
| New | +$1.13M | 0.12% | 223 |
|
|
2023
Q1 | – | Sell |
-22,610
| Closed | -$267K | – | 1079 |
|
|
2022
Q4 | $267K | Sell |
22,610
-5,015
| -18% | -$59.3K | 0.04% | 518 |
|
|
2022
Q3 | $164K | Buy |
27,625
+5,925
| +27% | +$35.2K | 0.03% | 548 |
|
|
2022
Q2 | $92K | Buy |
+21,700
| New | +$92K | 0.02% | 691 |
|